Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-04-19
1998-06-02
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514510, 514532, 514570, 548440, 560 10, 562426, 562427, A61K 3144
Patent
active
057600481
ABSTRACT:
The invention covers a novel series of .alpha.-mercaptoacrylic acid derivatives that inhibit both calpain I and calpain II with a high affinity and selectivity. The compounds are useful in the treatment of neurodegenerative disorders including cerebrovascular disorders, brain injury, spinal cord, and peripheral nerve injury, cardiac infarction, cataracts, inflammation, restenosis, muscular dystrophy, and platelet aggregation. Pharmaceutical compositions, methods of using processes for preparing and novel intermediates useful in the processes are also disclosed.
REFERENCES:
patent: 4124718 (1978-11-01), Giroux et al.
patent: 4169149 (1979-09-01), Giroux et al.
patent: 4347255 (1982-08-01), Giroux et al.
patent: 4439443 (1984-03-01), Giroux et al.
patent: 4999436 (1991-03-01), Witzel et al.
patent: 5554767 (1996-09-01), Wang et al
T. Murachi, Biochem Intl,1989, 18:263-294.
K. Wang, TiPS, 1990, 11:139-142.
B. Meldrum, et al., TiPS, Special Report: 1991, 54-92.
R. Siman, et al., J Neurosci, 1989, 9:5, 1579-1590.
A. Arai, et al., Brain Research, 1990, 532:63-68.
D. Holtzman, et al., TIBS 16, 1991, 140-144.
N. Iwamoto, et al., Brain Research, 1991, 561:177-180.
R. Siman, et al, J Neurosci, 1990, 10:7, 2400-2411.
T.R. Shearer, et al., Current Eye Research, 1987, 6:2, 289-300.
J.M. Marcantonio, et al., Biochemical Society Transactions, 1991, 19:1148-1150.
M. Azuma, et al., Current Eye Research, 1991, 10:7, 657-666.
N.L. Banik, et al., Central Nervous System Trauma, 1984, 1:2, 131-137.
W.C. Taft, et al., Soc Neurosciences Abs, 1991, 17:65.8.
N. Banik, et al., J Neurochemistry, 1985, 45:2, 581-588.
K. Iizuka, et al., Biochemical Medicine & Metabolic Biology, 1991, 46:427-431.
G. Toda, et al., Jpn Heart J, 1989, 30:3, 375-386.
W. McBride, et al., New England J of Medicine, 1988, 318:1734-1737.
K.L. March, et al., Clinical Research,1990, 38:2, 234A.
R.L. Wilensky, et al., JACC, 1991, 17:2, 268A.
I. Fukui, et al., Biochem & Biophy Res Comm, 1989, 162:2, 559-566.
K. Suzuki, et al., Biochem J, 1992, 285:857-862.
H. Sugita, et al., Calcium Regulation in Biological Systems,1984, ed. S. Ebashi, 243-256.
P. Johnson, et al., Int J Biochem, 1988, 20:11, 1227-1230.
R.N. Puri, American J Physiol, 1990, 259:C862.
J.J. Baldassare, et al., J Biological Chem, 1985, 260:19, 10531-10535.
R.N. Puri, et al., Blood, 1991, 77:3, 500-507.
B.L. Sharma, et al., J Applied Tox, 1986, 6:4, 253-257.
J. Wagner, et al., Can J Chem, 1977, 55:4028-4036.
T.H. Haskell, et al., J Med Chem, 1970, 13:4, 697-704.
Wang Kevin Ka-Wang
Yuen Po-Wai
Anderson Elizabeth M.
McKane Joseph
Solola Taofiq A.
Warner-Lambert & Company
LandOfFree
Alpha-mercaptoacrylic acid derivatives having calpain inhibitory does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-mercaptoacrylic acid derivatives having calpain inhibitory, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-mercaptoacrylic acid derivatives having calpain inhibitory will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1460124